Pfizer acts against Chinese fakes
22 May 2004
Pharmaceutical company Pfizer is to train Chinese officials on ways to spot fake medicines in an effort to tackle the country’s growing counterfeit drug problem
Pharmaceutical company Pfizer is to train Chinese officials on
ways to spot fake medicines in an effort to tackle the country's
growing counterfeit drug problem.
Pfizer last week signed a memorandum of understanding with the
Shanghai Municipal Food and Drug Administration to provide
medicines safety training to agency staff. The company signed a
similar agreement in December 2003 with the Shanghai Administration
for Industry...
Only subscribers have complete access to Managing IP Magazine,
log in or
subscribe now.
Alternatively take a
free trial, giving you 48-hour access to Managing IP Magazine (some articles and surveys may be excluded).
Subscribe Now
This article is available to subscribers. Please click subscribe to read the rest of the article.
Subscribe
Take a free trial
Please take a free 48-hour trial to gain limited access. Some articles and surveys may be excluded.
Take a free trial